Eduardo Garcia Vilela

Eduardo Garcia Vilela

Auto-generated profile, based on publicly available information

Eduardo Garcia Vilela

Universidade Federal de Minas Gerais, Brasil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
EVEduardo Garcia Vilela
Eduardo Garcia Vilela
MFMaria De Lourdes De Abreu Ferrari
Maria De Lourdes De Abreu Ferrari
HTHenrique Oswaldo Da Gama Torres
Henrique Oswaldo Da Gama Torres
APAdemar Guerra Pinto
Ademar Guerra Pinto
AAAna Carolina Carneiro Aguirre
Ana Carolina Carneiro Aguirre
ACAloísio Sales Da Cunha
Aloísio Sales Da Cunha
Objective. Crohn's disease (CD) is characterized by a reduction in mucosal integrity that permits antigen penetration into the intestinal tissue. The administration of probiotics has been suggested to improve the barrier function of the mucosa. The objective of this study was to evaluate the influence of Saccharomyces boulardii on the intestinal permeability in CD. Material and methods. Thirty-four patients were randomized according to the Vienna classification for treatment with either placebo or Saccharomyces boulardii. Baseline medications (mesalamine, azathioprine, prednisone, metronidazole and/or thalidomide) were maintained. Intestinal permeability (lactulose/mannitol ratio) was evaluated immediately before the beginning of treatment and at the end of the first and third treatment month. Fifteen healthy volunteers were also submitted for the intestinal permeability test. Results. In volunteers, the lactulose/mannitol ratio was 0.005±0.0037, whereas this value was 0.021±0.01 in patients with CD (p=0.001). In the placebo group, there was an increase in lactulose/mannitol ratio by 0.004±0.010 (p=0.12) at the end of the third month. In the S. boulardii group, there was an improvement in intestinal permeability, with a decrease in the lactulose/mannitol ratio by 0.008±0.006 (p=0.0005) in the same period. Conclusions. Patients with CD in remission present alterations in the integrity of the intestinal mucosal barrier according to lactulose/mannitol ratio. S. boulardii added to baseline therapy improved intestinal permeability in these patients, even though complete normalization was not achieved.

1 January 2012 in World Journal of Gastroenterology
Verified
Journal Article
Open access
EVEduardo Garcia Vilela
Eduardo Garcia Vilela
HTHenrique Osvaldo Da Gama Torres
Henrique Osvaldo Da Gama Torres
FMFabiana Paiva Martins
Fabiana Paiva Martins
MFMaria De Lourdes De Abreu Ferrari
Maria De Lourdes De Abreu Ferrari
MAMarcella Menezes Andrade
Marcella Menezes Andrade
ACAloísio Sales Da Cunha
Aloísio Sales Da Cunha
Crohn's disease and ulcerative colitis evolve with a relapsing and remitting course. Determination of inflammatory state is crucial for the assessment of disease activity and for tailoring therapy. However, no simple diagnostic test for monitoring intestinal inflammation is available. Noninvasive markers give only indirect assessments of disease activity. Histopathological or endoscopical examinations accurately assess inflammatory activity, but they are invasive, time consuming and expensive and therefore are unsuitable for routine use. Imaging procedures are not applicable for ulcerative colitis. The usefulness of ultrasound and Doppler imaging in assessing disease activity is still a matter of discussion for Crohn's disease, and an increased interest in computed tomography enterograph (CTE) has been seen, mainly because it can delineate the extent and severity of bowel wall inflammation, besides detecting extraluminal findings. Until now, the available data concerning the accuracy of magnetic resonance enterography in detecting disease activity is less than CTE. Due to this, clinical activity indices are still commonly used for both diseases.

7 April 2009 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
EVE.G. Vilela
E.G. Vilela
WCW.T. Clemente
W.T. Clemente
RMR.R.L. Mira
R.R.L. Mira
HTH.O.G. Torres
H.O.G. Torres
LVL.F. Veloso
L.F. Veloso
ALA.S. Lima
A.S. Lima

1 December 2008 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
EVE.G. Vilela
E.G. Vilela
HTH.O.G. Torres
H.O.G. Torres
MFM.L.A. Ferrari
M.L.A. Ferrari
ALA.S. Lima
A.S. Lima
ACA.S. Cunha
A.S. Cunha
The gut barrier monitors and protects the gastrointestinal tract from challenges such as microorganisms, toxins and proteins that could act as antigens. There is evidence that gut barrier dysfunction may act as a primary disease mechanism in intestinal disorders. The aim of the present study was to evaluate the barrier function towards sugars after the appropriate treatment of celiac disease and Crohn's disease patients and compare the results with those obtained with healthy subjects. Fifteen healthy volunteers, 22 celiac disease patients after 1 year of a gluten-free diet, and 31 Crohn's disease patients in remission were submitted to an intestinal permeability test with 6.0 g lactulose and 3.0 g mannitol. Six-hour urinary lactulose excretion in Crohn's disease patients was significantly higher than in both celiac disease patients (0.42 vs 0.15%) and healthy controls (0.42 vs 0.07%). Urinary lactulose excretion was significantly higher in celiac disease patients than in healthy controls (0.15 vs 0.07%). Urinary mannitol excretion in Crohn's disease patients was the same as healthy controls (21 vs 21%) and these values were significantly higher than in celiac disease patients (10.9%). The lactulose/mannitol ratio was significantly higher in Crohn's disease patients in comparison to celiac disease patients (0.021 vs 0.013) and healthy controls (0.021 vs 0.003) and this ratio was also significantly higher in celiac disease patients compared to healthy controls (0.013 vs 0.003). In spite of treatment, differences in sugar permeability were observed in both disease groups. These differences in the behavior of the sugar probes probably reflect different mechanisms for the alterations of intestinal permeability.

8 October 2013 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ASAlexandre Lages Savassi-Rocha
Alexandre Lages Savassi-Rocha
MDMarco Túlio Costa Diniz
Marco Túlio Costa Diniz
EVEduardo Garcia Vilela
Eduardo Garcia Vilela
MDMaria de Fátima Haueisen Sander Diniz
Maria de Fátima Haueisen Sander Diniz
SSSoraya Rodrigues de Almeida Sanches
Soraya Rodrigues de Almeida Sanches
IBInara Kellen Fonseca Balbino
Inara Kellen Fonseca Balbino

14 March 2007 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
EVEduardo Garcia Vilela
Eduardo Garcia Vilela
MFMaria de Lourdes de Abreu Ferrari
Maria de Lourdes de Abreu Ferrari
HTHenrique Osvaldo de Gama Torres
Henrique Osvaldo de Gama Torres
FMFabiana Paiva Martins
Fabiana Paiva Martins
EGEugênio Marcos Andrade Goulart
Eugênio Marcos Andrade Goulart
ACAloíso Sales da Cunha
Aloíso Sales da Cunha